| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.592 | 678 | 162.225 | 197.633 | 61.316 | 464.538 | 73.752 | 89.790 | 46.523 | 190.340 |
| Total Income - EUR | 10.592 | 678 | 164.055 | 197.633 | 61.323 | 465.501 | 75.210 | 90.127 | 46.606 | 190.468 |
| Total Expenses - EUR | 12.525 | 7.285 | 55.640 | 74.295 | 44.786 | 282.606 | 36.979 | 45.710 | 43.088 | 110.456 |
| Gross Profit/Loss - EUR | -1.933 | -6.608 | 108.415 | 123.338 | 16.537 | 182.895 | 38.231 | 44.417 | 3.518 | 80.012 |
| Net Profit/Loss - EUR | -2.250 | -6.628 | 106.627 | 121.362 | 15.924 | 179.541 | 37.573 | 43.535 | 3.108 | 74.416 |
| Employees | 1 | 1 | 2 | 4 | 4 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Pharmator S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.967 | 668 | 16.065 | 24.139 | 21.791 | 30.576 | 26.508 | 43.213 | 36.650 | 29.612 |
| Current Assets | 87.564 | 81.329 | 174.457 | 211.037 | 187.012 | 198.304 | 172.828 | 43.105 | 16.510 | 52.786 |
| Inventories | 0 | 0 | 1.019 | 1.421 | 1.791 | 734 | 5.117 | 681 | 710 | 675 |
| Receivables | 87.294 | 81.097 | 126.891 | 152.194 | 147.909 | 136.336 | 134.693 | 25.928 | 9.035 | 44.636 |
| Cash | 270 | 232 | 46.548 | 57.422 | 37.312 | 61.234 | 33.018 | 16.495 | 6.765 | 7.475 |
| Shareholders Funds | 89.366 | 81.826 | 107.153 | 121.878 | 135.441 | 216.663 | 189.850 | 44.021 | 31.164 | 74.899 |
| Social Capital | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 166 | 171 | 83.369 | 113.298 | 73.362 | 12.216 | 9.492 | 42.296 | 21.995 | 7.500 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
7112
|
|||||||||
Comments - Pharmator S.r.l.